News
PCR Biosystems launches advanced Bst Polymerase reagents for accelerated DNA and RNA amplification
PCR Biosystems, the UK-based specialists in DNA and RNA analysis, have launched a range of IsoFast™ Bst Polymerase reagents for rapid, robust and sensitive...
Industry Reports
Press Ganey Report on Health Care Safety Culture Prior to and During the COVID-19 Pandemic Finds Downward Trend Continues
Press Ganey released its newest research brief, Reverse the Trend: Improving Safety Culture in the COVID-19 Era. Analyses of national safety culture data and...
Clinical Trials
Moderna starts Phase I study of new Covid-19 vaccine candidate
Moderna Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced that the first participants have been dosed in the Phase 2/3...
News
AstraZeneca to supply the US with up to half a million additional doses of the potential COVID-19 antibody treatment AZD7442
AstraZeneca has modified an existing agreement with the US Government to supply up to 500,000 additional doses of AZD7442, a long-acting antibody (LAAB) combination...
Drug Research
Tevogen Bio, BioCentriq Partner for COVID T-cell Therapy
Tevogen Bio has entered a partnership with BioCentriq, a New Jersey based cell and gene therapy development and manufacturing center, to support clinical manufacturing...
Press Releases
PCI Broadens Clinical Trial Service Offerings at Berlin Facility
PCI Pharma Services is today pleased to announce a new milestone in our global Clinical footprint with the expansion of cold chain clinical supply...
News
Novartis presents positive data from Zolgensma for essential one-time treatment for SMA at MDA virtual conference
Novartis announced new data that reinforce the transformational benefit of Zolgensma (onasemnogene abeparvovec), an essential one-time treatment for spinal muscular atrophy (SMA). The overall...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read